The company
OneMedNet Corp
ONMD · Nasdaq
ONMD stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 41 weeks. It is 38.0% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 41
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $7.4M
- Insider sales, 12 months
- $321K
- Officials’ trades on record
- 0
- Institutions holding
- 21 (+1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Jeffrey YuChief Medical Officer | bought | 45,126at $5.54 | 9 Oct 2026filed 13 Oct 2026 |
| Thomas KosasaDirector, 10% owner | bought | 129,758at $5.78 | 7 Oct 2026filed 13 Oct 2026 |
| Aaron GreenChief Executive Officer | sold | 1,667at $6.48 | 24 Sep 2026filed 9 Oct 2026 |
| Aaron GreenChief Executive Officer | sold | 5,000at $7.39 | 22 Sep 2026filed 9 Oct 2026 |
| Robert Lawrence GoldenChief Financial Officer | sold | 3,000at $6.63 | 21 Sep 2026filed 9 Oct 2026 |
| Robert Lawrence GoldenChief Financial Officer | sold | 3,000at $6.30 | 15 Sep 2026filed 9 Oct 2026 |
| Robert Lawrence GoldenChief Financial Officer | sold | 2,500at $6.60 | 14 Sep 2026filed 9 Oct 2026 |
| Jeffrey YuChief Medical Officer | bought | 142,857at $0.63 | 10 Sep 2026filed 14 Sep 2026 |
| Thomas KosasaDirector, 10% owner | bought | 1,449,275at $0.69 | 30 Jul 2026filed 7 Aug 2026 |
| Jeffrey YuChief Medical Officer | bought | 158,730at $0.63 | 23 Jun 2026filed 24 Jun 2026 |
| Aaron GreenChief Executive Officer | bought | 36,650at $0.5733 | 23 Jun 2026filed 24 Jun 2026 |
| Jeffrey YuChief Medical Officer | bought | 172,414at $0.58 | 16 Jun 2026filed 17 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Savant Capital, LLCnew · filed 10 Aug 2026 | 7,219,243$5.1M | +7,219,243 |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,152,210$819K | +36,645+3.3% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 334,332$238K | -4,196−1.2% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 137,706$98K | +1,093+0.8% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 120,980$86K | +50,884+72.6% |
| STATE STREET CORPunchanged · filed 7 Aug 2026 | 116,700$83K | 00.0% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CTunchanged · filed 14 Aug 2026 | 112,252$80K | 00.0% |
| PNC Financial Services Group, Inc.added · filed 7 Aug 2026 | 103,332$73K | +86,072+498.7% |
| OpenArc Corporate Advisory, LLCadded · filed 5 Aug 2026 | 97,413$69K | +86,071+758.9% |
| NORTHERN TRUST CORPreduced · filed 13 Aug 2026 | 46,835$33K | -8,109−14.8% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.